Getinge has announced the inauguration of its new Global Centre of Excellence for Chemistry in the United Kingdom
Swedish medical technology company, Getinge, has announced the inauguration of its new Global Centre of Excellence for Chemistry in the United Kingdom. The new center will also become the company’s UK-based headquarters.
According to a Jan. 24, 2024 press release, the new facility, which will be inaugurated on Jan. 31, 2024 in St. Modwen Park, Derby, UK, will bring together the company’s chemistry and instrument decontamination businesses. Additionally, the company’s UK sales offices, service functions, and logistics operations will be housed in the new center.
“With the growth of our chemistry production volumes and the density of our innovation roadmap, we took the decision to invest into a larger and more modern facility,” said Stéphane Le Roy, president Surgical Workflows at Getinge, in the press release. “It will allow us to serve more hospitals globally, provide a better work environment for our teams, and improve our innovation capacity and quality control.”
“[This center represents a] new era for our teams where, for the first time in our UK Getinge history, all employees can come together under ‘one roof’,” added Avril Forde, president North Europe Region at Getinge, in the press release. “The new experience centre and educational facilities allows us to demonstrate Getinge’s technologies and vast portfolio to existing and future customers, strengthening further our ambitions to be a ‘partner of choice’.”
“The new facility provides the very best environment for us to take full advantage of the combined competencies in chemistry and machine technology from within our organisation,” stated Bob Newsome, managing director at Getinge’s Centre of Excellence for Chemistry, in the press release. “We are confident that this will drive innovation, resulting in new products and improved solutions that compliment market trends and customer needs.”
Source: Getinge
Exosomes Field Advances with Milestones Achieved by EXO Biologics and ExoXpert
December 4th 2024EXO Biologics and ExoXpert, an EXO Biologics subsidiary, have received GMP certification of a European manufacturing facility for exosomes and have successfully loaded mRNA and DNA payloads into GMP-grade exosomes for drug delivery.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.